Security National Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.19M Buy
74,682
+25,654
+52% +$1.39M 0.38% 56
2026
Q1
$3.08M Buy
49,028
+353
+0.7% +$28.2K 0.45% 53
2025
Q4
$4.64M Sell
48,675
-1,122
-2% -$110K 0.67% 44
2025
Q3
$4.86M Buy
49,797
+4,526
+10% +$469K 0.74% 39
2025
Q2
$4.86M Buy
45,271
+6,102
+16% +$617K 0.84% 33
2025
Q1
$3.95M Buy
39,169
+37,045
+1,744% +$3.73M 0.75% 36
2024
Q4
$190K Buy
+2,124
New +$187K 0.03% 117

Other funds holding BSX

Security National Bank's BSX Position: Q2 2026 in Review

Security National Bank increased its Boston Scientific (BSX) stake by 52% in Q2 2026, buying an estimated $1.39M and bringing the position to 74,682 shares worth $3.19M. The position accounts for 0.38% of the portfolio, ranked #56.

Security National Bank first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.86M in Q2 2025. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Security National Bank held 74,682 shares of Boston Scientific worth $3.19M as of Q2 2026.
  • Security National Bank bought 25,654 Boston Scientific shares in Q2 2026, an estimated $1.39M.
  • Boston Scientific made up 0.38% of Security National Bank's portfolio in Q2 2026, its #56 holding.
  • Security National Bank first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Security National Bank's Boston Scientific position peaked at $4.86M in Q2 2025.
  • 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Security National Bank's 13F filing for Q2 2026, filed 15 Jul 2026.